黄片一区二区三区在线观看-亚洲av综合久久国产激情按摩店-欧美日韩国产长车超污-欧美日韩偷拍精品视频

首頁 > 產(chǎn)品目錄 > 信號通路 > Microbiology/Virology/ Anti-infection > HIV Protease > 扎西他濱

扎西他濱

ChemLeader 98+%

Zalcitabine (ddC; Dideoxycytidine; 2',3'-Dideoxycytidine)

產(chǎn)品編號：CL2159 CAS No.：7481-89-2 MDLNo： 分子式：C9H13N3O3 分子量：211.22

加入收藏分享給朋友

規(guī)格	庫存	目錄價	會員專享價	數(shù)量
100 mg	In-stock	￥600.00	登錄后可見	- +
250 mg	In-stock	￥960.00	登錄后可見	- +
500 mg	3-5days	￥1536.00	登錄后可見	- +

化學(xué)品安全說明書(MSDS)

下載MSDS

質(zhì)檢證書(COA)

下載COA

發(fā)送詢價加入購物車

基本信息
相關(guān)文檔
產(chǎn)品詳情
相關(guān)文獻(xiàn)

基本信息

英文名稱	Zalcitabine (ddC; Dideoxycytidine; 2',3'-Dideoxycytidine)
中文名稱	扎西他濱
CAS號	7481-89-2
分子式	C9H13N3O3
分子量	211.22
外觀	White to light yellow powder
儲存條件	Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).

產(chǎn)品詳情

Zalcitabine (trade name Hivid) is a nucleoside analog HIV reverse transcriptase inhibitor (NARTI). It is an antiviral pyrimidine nucleoside analogue effective against HIV replication. 2′,3′-Dideoxycytidine, when activated to its triphosphate, is incorporated into DNA by HIV-1 RT (HIV-1 reverse transcriptase), causing DNA chain termination and viral replication. Zalcitabine was the third antiretroviral to be approved by the Food and Drug Administration (FDA) for the treatment of HIV/AIDS. It is used as part of a combination regimen. Zalcitabine appears less potent than some other nucleoside RTIs, has an inconvenient three-times daily frequency and is associated with serious adverse events. For these reasons it is now rarely used to treat human immunodeficiency virus (HIV), and it has even been removed from pharmacies entirely in some countries.

相關(guān)文獻(xiàn)

抱歉，暫時沒有相關(guān)文獻(xiàn)

相關(guān)產(chǎn)品

抱歉，暫時沒有相關(guān)產(chǎn)品

瀏覽記錄

CL2159

扎西他濱

7481-89-2 98+% In-stock

￥600.00 100 mg